机器人辅助步行治疗对脊髓损伤后亚急性期泌尿动力学变化的影响:一项前性研究
Zbigniew Ziętek1, Justyna Frasuńska2, Bogumił Korczyński3
1Department of Functional and Clinical Anatomy, Pomeranian Medical University, Szczecin, Poland.
概括
机器人辅助步行治疗 (RAGT) 显示出改善脊髓损伤 (SCI) 患者膀功能的潜力. RAGT可以提高尿流速并减少排尿时间,这表明它可以用于神经性膀治疗.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 脊髓损伤 (SCI) 经常导致膀功能障碍,增加上泌尿道并发症的风险.
- 尿动力学是评估SCI后膀功能的黄金标准.
- 机器人辅助步行疗法 (RAGT) 对泌尿功能的影响仍未得到充分研究.
研究的目的:
- 研究RAGT对SCI患者泌尿动力学参数的影响.
- 为了评估 RAGT 后膀容量,排泄参数和关功能的变化.
主要方法:
- 35名SCI患者 (受伤后3个月至2年) 被随机分配到RAGT (使用外骨) 或对照 (动态模板) 组.
- 治疗涉及7周,30分钟的会议.
- 在治疗前和治疗后进行了尿动力学评估,包括囊泡测量膀容量 (CBC),欲排便 (FD,ND,SD),流量,空气后残留体积 (PRV),服从性和管功能.
主要成果:
- 在所有患者中,RAGT与排尿时间的减少有关.
- 接受RAGT的不完整SCI患者显示流量增加和排尿时间减少.
- 在完整的SCI患者中,膀合规性保持稳定或略有下降;在不完整的SCI患者中,L级病变的SCI患者中,CBC和空白参数的变化很小.
结论:
- 膀参数的改善表明RAGT是SCI患者神经性膀管理的可行选择.
- RAGT可能对泌尿功能有好处,特别是在SCI不完整的个体中.
相关概念视频
Urodynamic Studies: Uroflowmetry
4.5K
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
4.5K
Spinal Cord
1.9K
The spinal cord, a critical component of the central nervous system, extends from the base of the brainstem to the lumbar region of the vertebral column. It is essential for maintaining physical stability and facilitating communication between the brain and peripheral parts of the body.
1.9K
The Spinal Cord
31.9K
The spinal cord is the body’s major nerve tract of the central nervous system, communicating afferent sensory information from the periphery to the brain and efferent motor information from the brain to the body. The human spinal cord extends from the hole at the base of the skull, or foramen magnum, to the level of the first or second lumbar vertebra.
31.9K
Spinal Cord: Information Processing
3.6K
The spinal cord is an integral hub for motor and sensory information that enables the brain to communicate with the peripheral nervous system (PNS). This communication consists of relaying sensory data and transmission of motor commands.
Sensory Information Processing
Sensory information processing begins at the sensory receptors located in the skin and other tissues, which detect somatic sensory stimuli such as touch, temperature, or pain. These receptors function as catalysts, initiating...
Sensory Information Processing
Sensory information processing begins at the sensory receptors located in the skin and other tissues, which detect somatic sensory stimuli such as touch, temperature, or pain. These receptors function as catalysts, initiating...
3.6K
Spinal Cord: Gross Anatomy
5.9K
The spinal cord resides within the protective confines of the vertebral column. It is the main pathway for information traveling between the brain and the body. It plays a fundamental role in nearly all bodily functions, from simple reflexes to complex motor movements. The spinal cord begins at the medulla oblongata at the base of the brainstem and extends downward, terminating at the conus medullaris near the first and second lumbar vertebrae. The spinal cord's length in adults is...
5.9K
Drug Administration and Therapy Phases: Overview
1.4K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.4K


